A new study examined how treatments for atrial fibrillation (Afib) affected cognitive decline and frailty. Treating heart rate compared to rhythm was linked to a greater rate of cognitive decline, the ...

In randomized trials in patients with atrial fibrillation (AF), treatment strategies that restore and maintain sinus rhythm (rhythm control) have not shown convincing advantages over those that simply ...

Early rhythm control with ablation or antiarrhythmic drugs is associated with a lower risk of adverse cardiovascular outcomes compared with rate control in patients with newly diagnosed atrial ...

March 5, 2004 — The results of a substudy from the Rate Control Versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) trial find that patients with persistent atrial fibrillation ...

The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally ...

Sophia Antipolis, 27 March 2023: Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces cardiovascular deaths, strokes, and other adverse outcomes by 20% compared ...

Old concerns about the safety of rhythm control drugs for atrial fibrillation (Afib or AF) resurfaced in a contemporary large Korean population-based study. Afib patients prescribed antiarrhythmic ...

Dear Dr. Roach: I was diagnosed with atrial fibrillation in January 2012. I am aware of when it comes by how I feel — a little out of sorts, but no shortness of breath, chest pain or light-headedness.